Loading...
XASX
RMD
Market cap27bUSD
Jun 18, Last price  
26.50AUD
1D
-3.81%
1Q
-17.52%
Jan 2017
208.86%
Name

Resmed Inc

Chart & Performance

D1W1MN
XASX:RMD chart
P/E
1.93
P/S
0.52
EPS
9.66
Div Yield, %
2.36%
Shrs. gr., 5y
0.23%
Rev. gr., 5y
11.72%
Revenues
5.15b
+9.84%
606,996,000716,332,000835,397,000920,735,0001,092,357,0001,243,148,0001,368,515,0001,514,457,0001,554,973,0001,678,912,0001,838,713,0002,066,737,0002,340,196,0002,606,572,0002,957,013,0003,196,825,0003,578,127,0004,222,993,0004,685,297,0005,146,327,000
Net income
1.40b
+37.20%
88,211,00066,302,000110,303,000146,448,000190,085,000226,986,000254,850,000307,133,000345,273,000352,886,000352,408,000342,284,000315,588,000404,592,000621,674,000474,505,000779,437,000897,556,0001,020,951,0001,400,723,000
CFO
1.75b
+25.00%
99,028,00091,106,000137,836,000238,877,000188,213,000283,190,000383,159,000402,823,000391,268,000383,180,000547,932,000414,053,000505,026,000459,051,000802,255,000736,718,000351,147,000693,299,0001,401,260,0001,751,588,000
Dividend
Aug 14, 20240.53 AUD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Established in 1989 and headquartered in San Diego, California, ResMed Inc. stands as a global leader in health technology, specializing in the development, manufacturing, distribution, and marketing of advanced medical devices and sophisticated cloud-based software solutions for the healthcare industry. The company operates through two primary divisions: Sleep and Respiratory Care, and Software as a Service (SaaS). Within its Sleep and Respiratory Care segment, ResMed offers an extensive range of products designed to address various respiratory disorders. These include innovative technologies integrated into both medical and consumer devices, ventilation systems, diagnostic tools, and a variety of mask systems suitable for both hospital and home environments, complete with essential headgear and accessories. The segment also provides dental devices and cloud-based informatics software aimed at improving patient outcomes and streamlining business operations. ResMed's digital portfolio features several specialized platforms. AirView, a cloud-based system, facilitates remote monitoring and adjustment of patient device settings. For individuals managing sleep apnea, myAir is a personalized therapy management application offering vital support, educational resources, and troubleshooting assistance to enhance engagement and treatment adherence. Additionally, U-Sleep provides compliance monitoring solutions that help home medical equipment (HME) providers optimize their sleep programs. Further connectivity options include module and Propeller solutions, alongside the Propeller portal. The company's robust Software as a Service segment delivers a comprehensive suite of out-of-hospital software solutions. Brightree furnishes business management software and services tailored for providers in HME, pharmacy, home infusion, orthotics, and prosthetics. MatrixCare supplies care management and related ancillary solutions to senior living communities, skilled nursing facilities, life plan communities, home health, home care, hospice organizations, and associated accountable care organizations. Furthermore, HEALTHCAREfirst offers electronic health record (EHR) systems, software, billing and coding services, and analytics specifically designed for home health and hospice agencies. ResMed distributes its diverse range of products and services globally to sleep clinics, home healthcare dealers, and hospitals through a broad network of distributors and a dedicated direct sales force, covering approximately 140 countries worldwide.
IPO date
Jun 01, 1995
Employees
10,140
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT